Effect of a trivalent vaccine against Staphylococcus aureus mastitis lymphocyte subpopulations, antibody production, and neutrophil phagocytosis

Canadian Journal of Veterinary Research

Volumn 69, Issue 1, 2005, Pages 11-18

  Lee, Jai Wei ^a   O'Brien, Celia N ^b   Guidry, Albert J ^b   Paape, Max J ^b   Shafer Weaver, Kimberley A ^b   Zhao, Xin ^a  

^a MCGILL UNIVERSITY   (Canada)

^b AGRICULTURAL RESEARCH SERVICE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALUMINUM HYDROXIDE; ANTISERUM; BACTERIAL POLYSACCHARIDE; CD4 ANTIGEN; CD8 ANTIGEN; FREUND ADJUVANT; IMMUNOGLOBULIN G1; IMMUNOGLOBULIN G2; POLYSACCHARIDE VACCINE; STAPHYLOCOCCUS VACCINE; TRIPLE VACCINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY BLOOD LEVEL; ANTIBODY PRODUCTION; ANTIBODY RESPONSE; ARTICLE; BLOOD SAMPLING; CATTLE DISEASE; CELL ISOLATION; COMPARATIVE STUDY; EMULSION; IMMUNIZATION; IMMUNOGLOBULIN BLOOD LEVEL; INOCULATION; LYMPHOCYTE SUBPOPULATION; MONONUCLEAR CELL; NEUTROPHIL; NONHUMAN; PHAGOCYTOSIS; PUERPERIUM; SEROTYPE; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS INFECTION; SUPPRESSOR CELL;

ANIMALS; ANTIBODIES, BACTERIAL; ANTIGENS, BACTERIAL; BACTERIAL VACCINES; CATTLE; EMULSIONS; FEMALE; FREUND'S ADJUVANT; IMMUNOGLOBULIN G; LYMPHOCYTES; MASTITIS, BOVINE; NEUTROPHILS; PHAGOCYTOSIS; POLYSACCHARIDES, BACTERIAL; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS; TREATMENT OUTCOME;

ANIMALIA; BACTERIA (MICROORGANISMS); BOS TAURUS; BOVINAE; STAPHYLOCOCCUS; STAPHYLOCOCCUS AUREUS;

EID: 13244295480     PISSN: 08309000     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. Barkema HW, Schukken YH, Lam TJGM, Beiboer ML, Benedictus G, Brand A. Incidence of clinical mastitis in dairy herds grouped in three categories by bulk milk somatic cell counts. J Dairy Sci 1998;81:411-419.
2. Schukken YH, Leslie KE, Lam T. Staphylococcus aureus: incidence, prevalence and risk factors for intramammary infection. In: Proceedings. 32nd Annu Meet Natl Mastitis Counc 1993:19-26.
3. Fox LK, Hancock DD. The effect of segregation on prevention of intramammary infections by Staphylococcus aureus. J Dairy Sci 1989;72:540-544.
4. Kelton D, Godkin A, Alves D, et al. Effectiveness of biosecurity practices to limit the spread of Staphylococcus aureus on Ontario Sentinel dairy farms. J Dairy Sci 1999;82:61.
5. Almeida RA, Matthews KR, Cifrian E, Guidry AJ, Oliver SP. Staphylococcus aureus invasion of bovine mammary epithelial cells. J Dairy Sci 1996;79:1021-1026.
6. Hébert A, Sayasith K, Sénéchal S, Dubreuil P, Lagacé J. Demonstration of intracellular Staphylococcus aureus in bovine mastitis alveolar cells and macrophages isolated from naturally infected cow milk. FEMS Microbiol Letters 2000;193:57-62.
7. Hensen SM, Pavicic MJAMP, Lohuis JACM, Poutrel B. Use of bovine primary mammary epithelial cells for the comparison of adherence and invasion ability of Staphylococcus aureus strains. J Dairy Sci 2000;83:418-429.
8. Pankey JW, Boddie NT, Watts JL, Nickerson SC. Evaluation of protein A and a commercial bacterin as vaccines against Staphylococcus aureus mastitis by experimental challenge. J Dairy Sci 1985;68:726-731.
9. Watson DL, McColl ML, Davies HI. Field trial of a staphylococcal mastitis vaccine in dairy herds: clinical, subclinical and microbiological assessments. Aust Vet J 1996;74:447-450.
10. Barrio B, Vangroenweghe F, Dosogne H, Burvenich C. Decreased neutrophil bactericidal activity during phagocytosis of slime-producing Staphylococcus aureus strain. Vet Res 2000;31: 603-609.
11. Norcross NL, Opdebeeck JP. Encapsulation of Staphylococcus aureus isolated from bovine milk. Vet Microbiol 1993;8: 397-404.
12. Sompolinsky D, Samra Z, Karakawa WW, Vann WF, Schneerson R, Malik Z. Encapsulation and capsular types in isolated of Staphylococcus aureus from different sources and relationship to phage types. J Clin Microbiol 1985;22:828-834.
13. Guidry AJ, Fattom A, Patel A, O'Brien CN. Prevalence of capsular serotypes among Staphylococcus aureus isolates from cows with mastitis in the United States. Vet Microbiol 1997;59: 53-58.
14. Guidry AJ, Fattom A, Patel A, O'Brien CN, Shepherd S, Lohuis J. Serotyping scheme for Staphylococcus aureus isolated from cows with mastitis. Am J Vet Res 1998;59:1537-1539.
15. Relyveld EH. Recent developments with vaccines against bacterial protein toxins. In: Alouf JE, Fehrenbach FJ, Freer JH, Jeljaszewicz J, eds. Bacterial Protein Toxins. London: FEMS Symposium 24, Academic Press, 1984:217-226.
16. Poolman JT. Polysaccharides and membrane vaccines. In: Miziahi A, ed. Bacterial Vaccines. Advances in the biological process, Volume 13. New York: Wiley-Liss, 1990:57.
17. Gilbert FB, Poutrel B, Sutra L. Immunogenicity in cows of Staphylococcus aureus type 5 capsular polysaccharide-ovalbumin conjugate. Vaccine 1994;12:369-374.
18. Mosmann TR, Cherwinski H, Bond MW, Giedlin MA, Coffman RL. Two types of murine helper T cell clone. Definition according to profiles of lymphokine activities and secreted proteins. J Immunol 1986;136:2348-2357.
19. Fattom A, Schneerson R, Watson DC, Karakawa WW, Fitzgerald D, Pastan I. Laboratory and clinical evaluation of conjugate vaccines composed of Staphylococcus aureus type 5 and type 8 capsular polysaccharides bound to pseudomonas aeruginosa recombinant exoprotein A. Infect Immun 1993;61:1023-1032.
20. Mond JJ, Lees A, Snapper CM. T cell-independent antigens type 2. Ann Rev Immunol 1995;13:655-692.
21. Tollersrud T, Zernichow L, Andersen SR, Kenny K, Lund A. Staphylococcus aureus capsular polysaccharide type 5 conjugate and whole cell vaccines stimulate antibody responses in cattle. Vaccine 2001;19:3896-3903.
22. Yip HC, Karulin AY, Tary-Lehmann M, et al. Adjuvant-guided type-1 and type-2 immunity: infectious/noninfectious dichotomy defines the class of response. J Immunol 1999;162:3942-3949.
23. Stieneker F, Kersten G, van Bloois L, et al. Comparison of 24 different adjuvants for inactivated HIV-2 split whole virus as antigen in mice. Induction of titers of binding antibodies and toxicity of the formulations. Vaccine 1995;13:45-53.
24. Cox J, Coulter AR. Adjuvants - a classification and review of their modes of action. Vaccine 1997;15:248-256.
25. Shafer-Weaver KA, Corl CM, Sordillo LM. Shifts in bovine CD4+ subpopulations increase T-helper-2 compared with T-helper-1 effector cells during the postpartum period. J Dairy Sci 1999;82:1696-1706.
26. O'Brien CN, Guidry AJ, Fattom A, Shepherd S, Douglass LW, Westhoff DC. Production of antibodies to Staphylococcus aureus serotypes 5, 8, and 336 using poly(DL-lactide-co-glycolide) microspheres. J Dairy Sci 2000;83:1758-1766.
27. Guidry AJ, Berning LM, Hambleton CN. Opsonization of Staphylococcus aureus by bovine immunoglobulin isotypes. J Dairy Sci 1993;76:1285-1289.
28. SAS/STAT User's Guide, Version 8, SAS Institute, Cary, North Carolina, USA, 2000.
29. Oliver SP, Sordillo LM. Udder health in the periparturient period. J Dairy Sci 1988;71:2584-2660.
30. González-Fernández M, Carrasco-Marin E, Alvarez-Dominguez C, Outschoorn IM, Leyva-Cobián F. Inhibitory effects of thymus-independent type 2 antigens on MHC class II-restricted antigen presentation: Comparative analysis of carbohydrate structures and the antigen presenting cell. Cellular Immunol 1997;176: 1-13.
31. Harp JA, Nonnecke BJ. Regulation of mitogenic response by bovine milk leukocytes. Vet Immunol Immunopathol 1986; 11:215-224.
32. Howard CJ, Taylor G, Brownlie J. Surface receptors for immunoglobulin on bovine polymorphonuclear neutrophils and macrophages. Res Vet Sci 1980;29:128-130.
33. Forsthuber T, Yip HC, Lehmann PV. Induction of TH1 and TH2 immunity in neonatal mice. Science 1996;271:1728-1730.
34. Weeratna RD, McCluskie MJ, Xu Y, Davis HL. CpG DNA induces stronger immune responses with less toxicity than other adjuvants. Vaccine 2000;18:1755-1762.